INSIGHTS ON CELL & GENE THERAPY DISCOVERY

• Powering More Efficient Clinical Development With AI And ML

  Explore how AI and ML are revolutionizing clinical trials by automating data processes to accelerate research and transform data into actionable outcomes for patient care.

• Securing A Treatment Through Grit And Collaboration

  Discover how one family defied the odds—bringing a lifesaving gene therapy from idea to treatment in just 14 months after a devastating rare disease diagnosis.

• Ready To Demystify Organoids?

  Organoids are transforming biomedical research. Explore their top applications, research workflows, key challenges, and dissociation techniques in this comprehensive guide to personalized medicine.

• Ethical, Considerations As Gene Editing Technologies Advance

  Observe as experts highlight innovative tools and strategies advancing the safety of gene editing therapies while addressing off-target effects, regulatory demands, and manufacturing efficiency.

• How The Pharma Industry Is Closing Health Inequities

  Witness as pharma leaders discuss advancing equity through inclusive trial design, access planning, and global partnerships to overcome persistent health disparities and expand access to lifesaving therapies worldwide.

• Guide To Seeding, Expanding, And Harvesting Stem Cells

  Investigate important considerations for working with three different stem cell types: mesenchymal stem/stromal cells, induced pluripotent stem cells, and neural stem cells.

• What ASCO 2025 Means For The Future Of Oncology Trials

  Review the ASCO 2025 Annual Meeting, highlighting oncology trials and the need for agile, globally capable CRO partners to navigate today’s evolving trial landscape.

• Factors Influencing CD34+ Cell Collection Efficiency In Leukapheresis

  Efficiently collecting sufficient peripheral blood stem cells is paramount for successful transplantation, necessitating a deeper understanding of influencing factors and procedural nuances.

• Broad Biodistribution And Expression Of Allele-Selective LETI-101

  Discover how LETI-101, a novel precision-based CRISPR treatment, can leverage targeted delivery and broad brain distribution to transform Huntington's disease treatment.

• CRISPR Portfolio, Modalities Accelerate Candidate Identification

  See how this cutting-edge, AI-driven genome editing technology can accelerate the development of precise, clinically viable therapies for genetic diseases.